TELA Bio, Inc. Proceeds from Lines of Credit
TELA Bio, Inc. (TELA) reported Proceeds from Lines of Credit of $5.73 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2021-03-25
- TELA Bio, Inc. proceeds from lines of credit for the quarter ending 2018-12-31 was $820.00K.
- TELA Bio, Inc. proceeds from lines of credit for fiscal 2018 was $5.73M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|
| 2018-12-31 | $820.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.73M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $4.91M 10-Q · filed 2019-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |